Artivion Stock Forecast for 2023 - 2025 - 2030

Updated on 03/27/2024

Stock Rating
12
Price Target
$25.00
Consensus
Outperform
Upside
24.88%
Analysts
0
Stock Rating
12
Upside
24.88%
Analysts
0
Price Target
$25.00

Artivion Stock Forecast and Price Target

In recent months, notable analysts have provided yearlong price targets for Artivion, with the average target coming in at $25.00. If it were to be achieved, this would result in a potential upside of approximately 24.88 percent from the most recent closing price in March, 2024. The high end is $28.00, and the low is $22.00. You may be interested in rivals even if you aren't interested in Artivion stock.

$25.00

24.88% Upside

Buy
Buy

Artivion Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Artivion's Price has seen a drop from $34.39 to $0.00 – a 100.00% decrease. In the next year, analysts expect Fair Value to reach $0.00 – an increase of 100.00%. For the next eight years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
$0.00
2025 Fair Value Forecast
$38.52
2025 Fair Value Forecast
$38.52
2026 Fair Value Forecast
$35.77
2027 Fair Value Forecast
$23.49
2028 Fair Value Forecast
$28.18
2029 Fair Value Forecast
$32.25
2030 Fair Value Forecast
$34.73
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ABT Stock Forecast Abbott Laboratories Outperform 9
$120.19 Buy/Sell $118.92 4.83%
PFE Stock Forecast Pfizer Outperform 2
$28.37 Buy/Sell $32.87 10.82%
MDT Stock Forecast Medtronic Outperform 11
$85.50 Buy/Sell $92.47 11.11%
BSX Stock Forecast Boston Scientific Outperform 11
$66.12 Buy/Sell $70.14 8.89%
BDX Stock Forecast Becton Dickinson and Co Outperform 9
$239.50 Buy/Sell $284.47 16.91%

Artivion Revenue Forecast for 2023 - 2025 - 2030

Artivion's Revenue has increased by 39.79% In the last three years, going from $253.23M to $354.00M. In the next year, analysts expect Revenue to reach $384.26M – an increase of 8.55%. For the next eight years, the forecast is for Revenue to grow by 14.10%.

2024 Rev Forecast
$0.38B
2024 Rev Forecast
$0.38B
2025 Rev Forecast
$0.43B
2026 Rev Forecast
$0.40B
2027 Rev Forecast
$0.40B
2028 Rev Forecast
$0.39B
2029 Rev Forecast
$0.40B
2030 Rev Forecast
$0.40B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
EW Stock Forecast Edwards Lifesciences Corp Outperform 11
$90.83 Buy/Sell $91.18 1.84%
4543 Stock Forecast Terumo Outperform 18
¥5.63k Buy/Sell ¥4.97k -9.46%
BAX Stock Forecast Baxter International Inc Outperform 17
$43.48 Buy/Sell $44.86 3.50%

Artivion Dividend per Share Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SWAV Stock Forecast Shockwave Medical Outperform 4
$257.74 Buy/Sell $239.91 4.76%
PEN Stock Forecast Penumbra Outperform 9
$241.62 Buy/Sell $258.62 19.40%
GETI B Stock Forecast Getinge AB Outperform 18
kr206.40 Buy/Sell kr226.10 9.01%

Artivion Free Cash Flow Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MMSI Stock Forecast Merit Medical Systems Outperform 14
$74.61 Buy/Sell $89.25 19.29%
IART Stock Forecast Integra LifeSciences Holdings Hold 16
$36.22 Buy/Sell $46.60 20.10%
688016 Stock Forecast Shanghai MicroPort Endovascula... Buy 18
¥186.35 Buy/Sell ¥238.98 26.64%

Artivion EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Artivion's EBITDA has decreased from $27.68M to $14.57M – a 47.36% drop. Next year, analysts are expecting EBITDA to reach $73.54M – an increase of 404.74%. Over the next seven years, the forecast is for EBITDA to grow by 543.94%.

2024 EBITDA Forecast
$0.07B
2025 EBITDA Forecast
$0.09B
2026 EBITDA Forecast
$0.11B
2027 EBITDA Forecast
$0.07B
2028 EBITDA Forecast
$0.07B
2029 EBITDA Forecast
$0.08B
2030 EBITDA Forecast
$0.09B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ATRC Stock Forecast AtriCure Outperform 8
$36.92 Buy/Sell $55.00 55.74%
LMAT Stock Forecast LeMaitre Vascular Outperform 18
$64.78 Buy/Sell $59.86 8.06%
1302 Stock Forecast LifeTech Scientific Buy 16
HK$1.87 Buy/Sell HK$2.97 58.82%

Artivion EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Artivion's EBIT has decreased by 222.27%, going from $6.96M to $-8.51M. 4 analysts predict Artivion's EBIT will decrease by 375.68% in the next year, reaching $23.46M. By 2030, professionals predict that Artivion's EBIT will decrease by 627.78%, to $44.91M.

2024 EBIT Forecast
$0.02B
2025 EBIT Forecast
$0.04B
2025 EBIT Forecast
$0.04B
2026 EBIT Forecast
$0.05B
2027 EBIT Forecast
$0.04B
2028 EBIT Forecast
$0.04B
2029 EBIT Forecast
$0.04B
2030 EBIT Forecast
$0.04B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SILK Stock Forecast Silk Road Medical, Inc Outperform 7
$16.00 Buy/Sell $12.33 18.75%
ANGO Stock Forecast AngioDynamics Outperform 8
$5.47 Buy/Sell $16.33 155.94%
AVR Stock Forecast Anteris Technologies Ltd Buy 10
$19.20 Buy/Sell $28.00 45.83%

Artivion EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Artivion's EPS has seen a drop from $0.25 to $0.00 – a 100.00% decrease. In the next year, analysts expect EPS to reach $-0.03 – an increase of 100.00%. For the next eight years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
$-0.03
2025 EPS Forecast
$0.28
2025 EPS Forecast
$0.28
2026 EPS Forecast
$0.26
2027 EPS Forecast
$0.17
2028 EPS Forecast
$0.20
2029 EPS Forecast
$0.23
2030 EPS Forecast
$0.25
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ELUT Stock Forecast Elutia Buy 2
$3.94 Buy/Sell $0.00 26.90%
RUA Stock Forecast RUA Life Sciences 0
£0.10 Buy/Sell £0.66 560.00%
AVGR Stock Forecast Avinger Outperform 9
$3.31 Buy/Sell $5.00 51.06%